Physician profile
Ashish Rastogi
NPI 1659711554
$123,260.17
in general payments reported to CMS, 2019-2025
36 companies · $107K in 2025
The $107K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,535 · 2020: $3,088 · 2021: $2,552 · 2022: $1,068 · 2023: $525 · 2024: $4,209 · 2025: $107K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $105K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Food and Beverage: $2,206 · Travel and Lodging: $770 · Consulting Fee: $750 · Grant: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $105,196.18 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Food and Beverage | $2,206.05 |
| Travel and Lodging | $769.78 |
| Consulting Fee | $750.00 |
| Grant | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $106,340.91 | 2019-2025 | General - Therapies, General - Structural Heart, Avvigo Guidance System |
| Shockwave Medical, INC | $4,220.42 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $2,303.57 | 2019-2021 | |
| Edwards Lifesciences Corporation | $1,901.36 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Cook Medical LLC | $1,084.98 | 2019-2021 | |
| Medtronic Vascular, INC. | $981.75 | 2020 | |
| Abbott Laboratories | $978.41 | 2019-2025 | Xience Skypoint, Jot Dx, Aveir |
| Abiomed | $879.93 | 2022-2025 | Impella |
| Asahi Intecc USA, INC. | $791.85 | 2020-2022 | |
| Medtronic, INC. | $635.96 | 2021-2025 | Symplicity G3, Corevalve Evolut R |
| Amgen INC. | $578.54 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $366.12 | 2019-2023 | Farxiga |
| Chiesi USA, INC. | $254.10 | 2019-2025 | Kengreal |
| Janssen Pharmaceuticals, INC | $201.78 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $198.14 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $194.99 | 2021-2025 | Lifevest |
| Cardiovascular Systems INC. | $185.20 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.27 | 2019-2025 | Jardiance |
| Stryker Corporation | $148.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $104.23 | 2022-2025 | Camzyos, Eliquis |
| Inspire Medical Systems, INC. | $94.73 | 2025 | Inspire |
| Acist Medical Systems, INC. | $94.40 | 2020-2021 | |
| Livanova USA, INC. | $90.51 | 2023 | Lifesparc |
| Angiodynamics, INC. | $82.95 | 2023-2024 | Alphavac |
| Teleflex LLC | $82.36 | 2021-2025 | Supercross, Langston, Trapliner |
| Philips North America LLC | $66.66 | 2021 | |
| Esperion Therapeutics, INC. | $37.71 | 2023 | Nexletol |
| Pfizer INC. | $32.93 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $28.75 | 2023 | Inpefa |
| Terumo Medical Corporation | $24.51 | 2024 | Angio-Seal |
| Zoll Circulation INC | $22.50 | 2022 | |
| Merck Sharp & Dohme LLC | $19.30 | 2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $17.12 | 2023 | Uptravi, Opsumit |
| Bard Peripheral Vascular, INC. | $16.12 | 2025 | Lutonix Drug Coated Balloon |
| Sanofi-Aventis U.S. LLC | $15.04 | 2022 | |
| Baxter Healthcare | $14.55 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Rastogi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.